Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.107 (
DAT
)
1,471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The dopamine transporter is a plasma membrane protein that controls extracellular concentrations of the neurotransmitter dopamine. The physiological importance of the
DAT
provides the impetus for studies aimed at understanding the molecular mechanisms underlying regulation of the
DAT
gene. In this study, we identified a
DAT
-expressing neuroblastoma cell line (SK-N-AS) and employed it to investigate the transcriptional regulation of the human
DAT
gene. Two GC boxes (located at -130 and -60, respectively, relative to the transcriptional start site) were identified as important cis-acting elements mediating
DAT
promoter activity in dopaminergic SK-N-AS cells. Utilizing Sp-deficient Drosophila Schneider line (
SL-2
) cells, we showed that both Sp1 and Sp3 are strong activators of
DAT
transcriptional activity. Differential binding of Sp1 and Sp3 to the two GC boxes was demonstrated by electrophoretic mobility shift assays and super-shift assays. Our results indicate that the Sp1 family of proteins plays an important role in controlling the expression of the dopamine transporter gene within dopaminergic neurons.
...
PMID:Sp1 and Sp3 activate transcription of the human dopamine transporter gene. 1581 70